PI Name PI Organization Title Grant Number Initiative Program Director
Radisky, Derek C

Mayo Clinic Jacksonville
United States

Involution-based biomarkers of breast cancer risk 5R01CA237602-03 Christos Patriotis, Ph.D., M.Sc.
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer 5U01CA214254-05 Sharmistha Ghosh-Janjigian, Ph.D.
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery 3U01CA152990-10S2 Christos Patriotis, Ph.D., M.Sc.
Duncavage, Eric J

Washington University
United States

Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes 1UH2CA272904-01 PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) Lynn Sorbara, Ph.D.
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 1R37CA273959-01 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Richard Mazurchuk, Ph.D.
Chauhan, Subhash C.

University Of Texas Rio Grande Valley
United States

MUC13 Mucin in Colerectal Cancer Health Disparity 5R01CA204552-05 Matthew Young, Ph.D.
Roy, Hemant K.

Baylor College Of Medicine
United States

Microvasculature in Colon Field Carcinogenesis: Clinical-Biological Implications 5R01CA224911-05 Matthew Young, Ph.D.
Brennan, Paul Joseph

International Agency For Res On Cancer
United States

PROMINENT - IARC 1OT2CA278681-01 Sharmistha Ghosh-Janjigian, Ph.D.
Figueiredo, Jane C.

Cedars-Sinai Medical Center
United States

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 3U54CA260591-02S2 Christos Patriotis, Ph.D., M.Sc.
Chung, Fung-Lung

Georgetown University
United States

gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention 5U01CA220477-05 Wendy Wang, Ph.D., M.Sc.